Nissay Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Buy |
5,443
+208
| +4% | +$59.8K | 0.01% | 555 |
|
|
2025
Q1 | $1.61M | Buy |
5,235
+43
| +0.8% | +$13.3K | 0.01% | 557 |
|
|
2024
Q4 | $1.87M | Buy |
5,192
+61
| +1% | +$22K | 0.01% | 539 |
|
|
2024
Q3 | $1.84M | Sell |
5,131
-149
| -3% | -$53.4K | 0.01% | 549 |
|
|
2024
Q2 | $1.68M | Sell |
5,280
-122
| -2% | -$38.9K | 0.01% | 540 |
|
|
2024
Q1 | $1.24M | Buy |
5,402
+90
| +2% | +$20.7K | 0.01% | 606 |
|
|
2023
Q4 | $1.17M | Buy |
5,312
+218
| +4% | +$47.9K | 0.01% | 591 |
|
|
2023
Q3 | $1.15M | Buy |
5,094
+219
| +4% | +$49.5K | 0.01% | 581 |
|
|
2023
Q2 | $1.08M | Buy |
4,875
+213
| +5% | +$47K | 0.01% | 593 |
|
|
2023
Q1 | $1.04M | Buy |
+4,662
| New | +$1.04M | 0.01% | 598 |
|
|
2019
Q2 | – | Sell |
-5,029
| Closed | -$590K | – | 752 |
|
|
2019
Q1 | $590K | Buy |
5,029
+144
| +3% | +$16.9K | 0.02% | 613 |
|
|
2018
Q4 | $532K | Sell |
4,885
-70
| -1% | -$7.62K | 0.02% | 593 |
|
|
2018
Q3 | $634K | Buy |
4,955
+130
| +3% | +$16.6K | 0.02% | 595 |
|
|
2018
Q2 | $546K | Buy |
4,825
+128
| +3% | +$14.5K | 0.02% | 620 |
|
|
2018
Q1 | $528K | Buy |
4,697
+131
| +3% | +$14.7K | 0.02% | 615 |
|
|
2017
Q4 | $676K | Buy |
+4,566
| New | +$676K | 0.02% | 565 |
|